When both markers were used the success rate of the c-Met+/CD44+combination yielded tumours in 80% of cases injected with 1000 cells compared to the success rate of ALDH1high cells, which yielded tumours in 66.6% of cases [54]. The gene discussed is CD44; the disease is neoplasm.